IL6 and neoplasm: While IL-6 has been involved in the inhibition of DC differentiation, decreasing the stimulatory effect of DCs on T cells (53, 54), the secretion of IL-6 by MSCs has been shown to promote anti-tumor adaptive immunity by increasing T lymphocyte trafficking in the tumor microenvironment (181).